GlassScriptPhysician profile
Ruben Gerard Alexander
NPI 1790078848
$9,520.20
in general payments reported to CMS, 2019-2025
42 companies · $991 in 2025
The $991 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,746 · 2020: $324 · 2021: $294 · 2022: $898 · 2023: $1,118 · 2024: $1,150 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,192 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $67.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,192.16 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $67.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,581.27 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $623.45 | 2019-2025 | Belbuca, Xtampza, Nucynta |
| Abbott Laboratories | $606.81 | 2019-2025 | Proclaim, Octrode, Eterna |
| Medtronic, INC. | $495.24 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Vanta Adaptivestim |
| Zyla Life Sciences, INC. | $422.93 | 2019 | |
| Vertiflex, INC. | $391.40 | 2019 | |
| Scilex Pharmaceuticals INC. | $388.22 | 2019-2025 | Ztlido |
| Daiichi Sankyo INC. | $354.58 | 2019 | |
| Stimwave Technologies Incorporated | $340.15 | 2019-2022 | |
| Nevro Corp. | $330.69 | 2019-2022 | |
| Abbvie INC. | $293.19 | 2022-2025 | Botox, Ubrelvy |
| Biotronik Nro, INC. | $289.84 | 2023-2025 | Prospera, Biotronik |
| Boston Scientific Corporation | $256.74 | 2019-2025 | General - Pain Management |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $251.24 | 2019-2025 | Relistor |
| Lundbeck LLC | $222.83 | 2022-2025 | Vyepti |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stratus Medical, LLC | $182.24 | 2023 | Nimbus |
| Sentynl Therapeutics, INC. | $154.36 | 2019 | |
| Globus Medical, INC. | $153.93 | 2025 | Senza, Vyrsa V1 |
| Forte Bio-Pharma LLC | $152.61 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Allergan, INC. | $148.42 | 2019 | |
| Amgen INC. | $140.68 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.81 | 2024 | |
| Si-Bone, INC. | $78.30 | 2019-2024 | |
| Becton, Dickinson and Company | $67.00 | 2024 | |
| Vertos Medical, INC. | $66.40 | 2024 | Mild Device Kit |
| Vanda Pharmaceuticals INC. | $48.99 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $44.85 | 2024 | Xeomin |
| Vertical Pharmaceuticals, LLC | $43.70 | 2019 | |
| Pfizer INC. | $37.38 | 2019-2024 | |
| Spr Therapeutics, INC | $33.83 | 2021-2024 | Sprint Pns System |
| Protega Pharmaceutials INC | $32.76 | 2025 | Roxybond |
| Nalu Medical, INC. | $31.29 | 2024-2025 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $27.92 | 2023 | Evoke Scs |
| Takeda Pharmaceuticals U.S.A., INC. | $23.62 | 2019 | |
| Emd Serono, INC. | $18.37 | 2022 | |
| Novo Nordisk INC | $18.30 | 2021 | |
| Painteq LLC | $16.20 | 2024 | Painteq |
| Inogen, INC. | $15.72 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.51 | 2020 | |
| Curonix LLC | $13.56 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Arbor Pharmaceuticals, INC. | $11.03 | 2019 | |
| Assertio Therapeutics, INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruben Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.